Place of radiotherapy in the treatment of Graves' orbitopathy

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 4, 1999, Pages 805-815

  Beckendorf, Véronique ^a   Maalouf, Toufic ^b   George, Jean Luc ^b   Bey, Pierre ^a   Leclere, Jacques ^b   Luporsi, Elisabeth ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Graves' orbitopathy; Radiotherapy

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; DEPRESSION; DIABETES MELLITUS; EXOPHTHALMOS; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION; RADIATION CATARACT; RADIATION DOSE DISTRIBUTION; RADIATION RESPONSE; RETINOPATHY; SYMPTOM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 0033061894     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00405-2     Document Type: Article

References (52)

1. Fries P.D. Thyroid dysfunction Managing the ocular complications of Graves' disease . Geriatrics. 47:1992;58-60.
2. Bartley G.B., Fatourechi V., Kadrmas E.F., Jacobsen S.J., Ilstrup D.M., Garrity J.A., Gorman C.A. The treatment of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 121:1996;200-206.
3. Rosier Diallo L., Albnet J.L., Riss I., Le Rebeller M.J. Les neuropathies optiques dans la maladie de Basedow. Bull Soc Opht France. 91:1991;45-51.
4. Tallstedt L., Lundell G., Torring O., Wallin G., Ljunggren J.G., Blomgren H., Taube A. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med. 326:1992;1733-1738.
5. De Groot LJ, Gorman CA, Pinchera A, Bartalena L, Marocci C, Wiersinga WM, Prummel MF, Wartofski L. Therapeutic controversies. Radiation and Graves' ophthalmopathy. J Clin Endocrinol Metab. 1995;80:399-349.
6. Bartley G.B., Fatourechi V., Kadrmas E.F., Jacobsen S.J., Ilstrup D.M., Garrity J.A., Gorman C.A. Chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 121:1996;426-431.
7. Mandeville F.B. Roentgen therapy of orbital-pituitary portals for progressive exophthalmos following subthyroidal thyroidectomy. Radiology. 41:1943;268.
8. Paufique L., Papillon J., Guinet P. Le traitement roentgenothérapique des exophthalmies oedémateuses sans hyperthyroïdie. J Radiol Electrol. 32:1951;21-26.
9. Donaldson S.S., Bagshaw M.A., Kriss J.P. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab. 37:1973;276-285.
10. Werner S.C. Classification of the eye changes of Graves' disease. J Clin Endocrinol Metab. 29:1969;982-984.
11. Werner S.C. Modification of the classification of the eye changes of Graves' disease Recommendations of the Ad Hoc Committee of the American Thyroid Association . J Clin Endocrinol Metab. 44:1977;203-204.
12. Bartley G.B. Evolution of classification systems for Graves' ophthalmopathy. Ophthalmic Plast Reconstr Surg. 11:1995;229-237.
13. Seegenschmiedt M.H., Keilholz L., Becker W., Gusek G., Naumann G.O.H., Wolf F., Hensen J., Sauer R. Radiotherapy for severe, progressive thyroid-associated ophthalmopathy Long-term results with comparison of scoring systems . Front Radiat Ther Oncol. 30:1997;218-226.
14. Hartemann P., Leclère J., Bey P., Thomas J.L., Genton P. Le traitement des orbitopathies thyroïdiennes par la radiothérapie orbitaire externe. Ann Endocrinol (Paris). 47:1986;389-394.
15. Maalouf T., Angioi-Duprez K., Beckendorf V., Malet T., George J.L. Effets de la radiothérapie orbitaire externe sur le muscle oculomoteur dans l'ophthalmopathie thyroidienne [Effects of orbital radiotherapy on oculomotor muscles in Graves' disease]. J Fr Ophthalmol. 19:1996;748-754.
16. Wartelle M., Kramar A., Jan P. Pigas. An interactive statistical database management system. Hammond R., MacCarthy J.L. Proceedings of the Second International Workshop on Statistical Database Management. 1983;124-132 Statistics, Canada.
17. Bartalena L., Marcocci C., Chiovato L., Laddaga M., Lepri G., Andreani D., Cavallacci G., Baschieri L., Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves ophthalmopathy Comparison with systemic corticosteroids alone . J Clin Endocrinol Metab. 56:1983;1139-1144.
18. Wiersinga W.M., Smit T., Schuster-Uittenhoeve A.L.J., van der Gaag R., Koornneef F.L. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Ophthalmologica. 197:1988;75-84.
19. Prummel M.F., Mourits M.P., Blank L., Berghout A., Koornneef L., Wiersinga W.M. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet. 342:1993;949-954.
20. Friedrich A., Friedrich K., Goldmann A. Clinical importance of radiotherapy in the treatment of Graves' disease. Front Radiat Ther Oncol. 30:1997;195-205.
21. Olivotto A., Ludgate C.M., Allen L.H., Rootman J. Supervoltage radiotherapy for Graves' ophthalmopathy CCABC technique and results . Int J Radiat Oncol Biol Phys. 11:1985;2085-2090.
22. Petersen I.A., Kriss J.P., McDougall I.R., Donaldson S.S. Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol. 19:1990;259-264.
23. Kazim M., Trokel S., Moore S. Treatment of acute Graves' ophthalmopathy. Ophthalmology. 98:1991;1443-1448.
24. Staar S., Müller R.P., Hammer M., Nolte M. Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves' disease). Front Radiat Ther Oncol. 30:1997;206-217.
25. Lloyd W.C., Leone C.R. Jr. Supervoltage orbital radiotherapy in 36 cases of Graves' disease. Am J Ophthalmol. 113:1992;374-380.
26. Pfluger T., Toroutoglou N., Pickardt C., Wuttge R. Retrobulbar irradiation of endocrine ophthalmopathy A comparison between 10 and 16 Gy total dose . Strahlenther Oncol. 166:1990;673-677.
27. Snijders-Keilholz A., De Keizer R.J.W., Goslings B.M., Van Dam E.W.C.M., Jansen J.T.H.M., Broerse J.J. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy. Radiother Oncol. 38:1996;69-71.
28. Lyons C.J., Rootman J. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy. Ophthalmology. 101:1994;223-230.
29. Mourits M.P., Koornneef L., Wiersinga W.M., Prummel M.F., Berghout A., Van der Gaad R. Orbital decompression for Graves' ophthalmopathy by inferomedial plus lateral and by coronal approach. Ophthalmology. 97:1990;636-641.
30. Trokel S., Kazim M., Moore S. Orbital fat removal. Decompression for Graves' orbitopathy. Ophthalmology. 100:1993;674-682.
31. Weisman R.A., Osguthorpe J.D. Orbital decompression in Graves' disease. Arch Otolaryngol Head Neck Surg. 12:1994;831-834.
32. Shak K.J., Dasher B.G., Brooks B. Computed tomography of Graves' ophthalmopathy Diagnosis, management, and posttherapeutic evaluation . Clin Imaging. 8:1989;253-264.
33. Kao S.C.S., Kendler D.L., Nugent R.A., Adler J.S., Rootman J. Radiotherapy in the management of thyroid orbitopathy. Arch Ophtalmol. 111:1993;819-823.
34. Wilson W.B., Prochoda M. Radiotherapy for thyroid orbitopathy Effects on extraocular muscle balance . Arch Ophthalmol. 113:1995;1420-1425.
35. Alberti W. Effects of radiation on the eye and ocular adnexa. Scherer E., Streffer C., Trott K.R. Radiopathology of organs and tissues. 1991;269-282 Springer-Verlag, Berlin, Heidelberg.
36. Mettler F.A., Upton A.C. Direct effects of radiation. Eye and ear. Mettler F.A., Upton A.C. Medical effects of ionizing radiation. 2nd ed. 1995;231-290 WB Saunders, Philadelphia.
37. Kinyoun J.L., Kalina R.E., Brower S.A., Mills R.P., Johnson R.H. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol. 102:1984;1473-1476.
38. Nikoskelainen E., Joensuu H. Retinopathy after Graves' ophthalmopathy. Lancet. 2:1989;690.
39. Miller M.L., Goldberg S.H., Bullock J.D. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol. 112:1991;600-601.
40. Blank L.E.C.M., Bardensen G.W., Prummel M.F., Stalpers L., Wiersinga W., Kornneef L. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy. Radiother Oncol. 40:1996;185-189.
41. Gayno J.P., Strauch G. Cyclosporine and Graves' ophthalmopathy. Hormone Res. 26:1987;190-197.
42. Prummel M.F., Mourits M.P., Berghout A., Krenning E.P., Van der Gaag R., Koornneef L., Wiersinga W.M. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med. 321:1989;1353-1359.
43. Corticosteroids - adverse effects. Reynolds J.E.F., Parfitt K., Parsons A., Sweetman S.C. Martindale. The extra pharmacoepia. 1996;1018-1029 Royal Pharmaceutical Society, London.
44. Raspiller A., Larcan A., Trechot P., Maalouf T. Intoxications et pathologie iatrogène. Flament J., Stork D. Oeil et pathologie générale. 1997;215-280 Masson, Paris.
45. Corticosteroids. Morton Grant W., Schuman J.S. Toxicology of the eye. 1993;454-474 Charles c. Thomas, Springfield.
46. Anonymous. Immunosuppressive drugs and their complications. Drug Ther Bull. 32:1994;66-78.
47. Antineoplastic agent and immunosuppressants - adverse effects. Reynolds J.E.F., Parfitt K., Parsons A., Sweetman S.C. Martindale. The extra pharmacoepia. 1996;512-516 Royal Pharmaceutical Society, London.
48. Kahaly G. Noncorticosteroids immunosuppressants in endocrine orbitopathy. Exp Clin Endocrinol. 97:1991;316-319.
49. Wiessel M., Zielinski C.C., Hauff W., Till P. Successful treatment of compressive optic neuropathy with Cyclosporin-A and cortisone in patients with Graves' ophthalmopathy. Acta Med Austriaca. 20:1993;1-2.
50. Amano K., Ezaki H., Mori M., Shinozaki K., Fujimoto K., Kadomoto H. Leukapheresis to patients with ophthalmic Graves' disease. Agishi T., et al. Therapeutic plasmapheresis (XII). 1993;83-86 VSP, Utrecht.
51. Atabay C., Schroonen M., Zhang Z.G., Salvi M., Glinoer D., Wall J.R. Use of eye muscle antibody measurements to monitor response to plasmapheresis in patients with thyroid-associated ophthalmopathy. J Endocrinol Invest. 16:1993;669-674.
52. De Rosa G., Corsello S.M., Della Casa S., Rossi P.L., Menichella G., Pasargiklian E. Plasma-exchange in the treatment of established chronic exophthalmos. Curr Ther Res. 31:1982;944-949.